11282 - Virginia Cancer Specialists

Trial ID 11282

Sponsor ID SGN35-015

A Phase 2 Open-Label Study of Brentuximab Vedotin in Front-Line Therapy of Hodgkins Lymphoma and CD30-expressing Peripheral T-Cell Lymphoma (PTCL) in Older Patients or Patients with Significant Comorbidities Ineligible for Standard Therapy

Principal Investigator

Dipti Patel-Donnelly, MD

4 Locations

Lymphoma

Locations

Fairfax Office

Gainesville Office

Arlington Office

Alexandria Office

Learn More About This Trial

Name*
First Last
Diagnosis / Trial Interested In*
Email*
Enter Email Confirm Email
Comments
Phone
CAPTCHA

Other Relevant Trials

Trial ID DR-01-ONC-001

Sponsor ID Dren Bio

A Multicenter, Open-Label, First-in-Human, Multiple Expansion Cohort, Phase 1/2 Study to Evaluate the Safety and Efficacy of DR-01 in Adult Subjects with Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Principal Investigator

Alexander I. Spira, MD, PhD, FACP

1 Location

Leukemia

Lymphoma

Trial ID ADCT-402-105

Sponsor ID LOTIS-7

A Phase 1b Open-Label Study to Evaluate the Safety and Anti-Cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-Cancer Agents in Patients with Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma